Furthermore, the diagnosis of MAFLD/MASLD-defined fatty liver disease based on a spectrum of metabolic syndromes including obesity may make CRP more applicable since both CRP and fatty liver are associated with metabolic disorders. The gene discussed is CRP; the disease is Obesity.